Episode 28: Moving up against the market

Eti Amegor of Axius Partners & www.suitsandkicks.com joins us to talk allocating and investing in the strange current environment. 0:52 - Opportunities during the coronavirus 1:55 - Current investor trends regarding liquidity 3:30 - The new private equity fund being launched by Eti's firm 6:30 - Why the coronavirus is the best environment for active investment managers 8:00 - Life Sciences stocks and the coronavirus 9:30 - Mike talks through Moderna, which focuses on drug discovery and  development based on messenger RNA 10:50 - Eti and Mike talk Afterpay (again) 14:00 - The endgame... Afterpay vs Paypal 16:55 - Why Frazis Capital does not buy Big Tech 17:10 - Mike introduces MercadoLibre, a new portfolio holding 18:30 - Mike introduces Sea, another new portfolio holding 20:00 - Shopify has performed superbly... is it still worth the valuation? 23:55 - Investment thematics within Frazis Capital Partners 25:20 - Mike discusses three digital health investment opportunities 28:30 - Frazis Capital's recent approach to a more diversified portfolio construction 34:30 - The fund's approach to adding new positions to the portfolio 37:10 - The underperformance of 70+ stock portfolios 41:00 - The issues that fund managers face when running highly consolidated portfolios 43:50 - Why Eti believes that Frazis Capital is in the 'sweet spot' 52:00 - Frazis Capital's up and coming webinar